{"date":"2025-09-11","count":10,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4162-2025-09-11-2130-1c7sldf","company_id":"4162","company":"智擎","market":"上櫃","industry":"生技醫療","date":"2025-09-11","time":"21:30:35","subject":"本公司官方網站代管廠商遭受網路DDoS攻擊","clause":"第26款","fact_date":"2025-09-11","cite_as":"公開資訊觀測站重大訊息：智擎（4162），2025-09-11 21:30，「本公司官方網站代管廠商遭受網路DDoS攻擊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4737-2025-09-11-1820-1uhskx3","company_id":"4737","company":"華廣","market":"上市","industry":"生技醫療","date":"2025-09-11","time":"18:20:08","subject":"公告本公司董事會決議辦理現金增資發行新股","clause":"第11款","fact_date":"2025-09-11","cite_as":"公開資訊觀測站重大訊息：華廣（4737），2025-09-11 18:20，「公告本公司董事會決議辦理現金增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6926-2025-09-11-1751-evrht5","company_id":"6926","company":"聖安生醫","market":"興櫃","industry":"生技醫療","date":"2025-09-11","time":"17:51:40","subject":"公告本公司與新加坡Esco Aster Pte. Ltd.簽署外泌體裝載小分子藥物專利技術授權合約","clause":"第8款","fact_date":"2025-09-11","cite_as":"公開資訊觀測站重大訊息：聖安生醫（6926），2025-09-11 17:51，「公告本公司與新加坡Esco Aster Pte. Ltd.簽署外泌體裝載小分子藥物專利技術授權合約」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2025-09-11-1651-5w5lga","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2025-09-11","time":"16:51:35","subject":"代重要子公司SMTH AG公告董事會決議通過以資本公積彌補虧損","clause":"第53款","fact_date":"2025-09-11","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2025-09-11 16:51，「代重要子公司SMTH AG公告董事會決議通過以資本公積彌補虧損」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1786-2025-09-11-1646-1yenohk","company_id":"1786","company":"科妍","market":"上市","industry":"生技醫療","date":"2025-09-11","time":"16:46:44","subject":"公告本公司Hyalush各劑型皮下填補劑產品取得銷售許可證書","clause":"第51款","fact_date":"2025-09-11","cite_as":"公開資訊觀測站重大訊息：科妍（1786），2025-09-11 16:46，「公告本公司Hyalush各劑型皮下填補劑產品取得銷售許可證書」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7850-2025-09-11-1631-1qw0mkw","company_id":"7850","company":"寶泰生醫","market":"興櫃","industry":"生技醫療","date":"2025-09-11","time":"16:31:52","subject":"本公司受邀參加統一證券2025Q3全球展望秋季投資論壇","clause":"第30款","fact_date":"2025-09-12","cite_as":"公開資訊觀測站重大訊息：寶泰生醫（7850），2025-09-11 16:31，「本公司受邀參加統一證券2025Q3全球展望秋季投資論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2025-09-11-1614-1ywsi7l","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2025-09-11","time":"16:14:03","subject":"公告本公司辦理股票初次上市前現金增資收足股款暨增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2025-09-11 16:14，「公告本公司辦理股票初次上市前現金增資收足股款暨增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2025-09-11-1613-11xsxub","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2025-09-11","time":"16:13:55","subject":"公告本公司辦理股票初次上巿過額配售內容","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2025-09-11 16:13，「公告本公司辦理股票初次上巿過額配售內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6535-2025-09-11-1611-1cza5x2","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2025-09-11","time":"16:11:10","subject":"本公司有價證券近期多次達公布注意交易資訊標準，故公告相關訊息，以利投資人區別暸解。","clause":"第53款","fact_date":"2025-09-11","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2025-09-11 16:11，「本公司有價證券近期多次達公布注意交易資訊標準，故公告相關訊息，以利投資人區別暸解。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4119-2025-09-11-1541-1p622qs","company_id":"4119","company":"旭富","market":"上市","industry":"生技醫療","date":"2025-09-11","time":"15:41:35","subject":"公告本公司研發主管異動。","clause":"第8款","fact_date":"2025-09-11","cite_as":"公開資訊觀測站重大訊息：旭富（4119），2025-09-11 15:41，「公告本公司研發主管異動。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}